Replies to post #4663 on InMed Pharmaceuticals Inc (INM)

[lesgetrich]

We know 2019 is a target for an uplist to the NASDAQ. I was originally thinking between 5-9. Looking at all the potential i wouldn't be surprised to see double that by the end of the year

Thoughts?

LOL If I were that good at predicting stock prices, I'd be a very wealthy man (I'm not). Pharma companies, particularly startups, are especially hard to predict since their pps is not based on financial fundamentals but potential revenues if/when their products hit the market, how close they are to a marketable product and a good dose of speculation. I can't predict where the pps will be a year from now. The one thing I'm confident about is that we'll be a lot higher than we are today.